Back to AI Artemis Investment Management LLP

BTAIQ

16 quarters

Position history for AIArtemis Investment Management LLP's holdings in BioXcel Therapeutics, Inc.

No. Artemis Investment Management exited its BTAIQ (BioXcel Therapeutics) position in Q3 2023. Its Q2 2023 13F listed 895,048 shares worth $6M. Artemis Investment Management held BTAIQ in 15 quarterly 13F filings before exiting.

Final Value

$0

Final Shares

0

Total Value Change

-$15.5M

Total Shares Change

-1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2023-Q3
Latest
Exited
0
-100.0%
$00.0%$40.48
0
2023-Q2
Decreased
895,048
-8.8%
$6M0.1%$106.56
0
2023-Q1
Decreased
981,472
-26.4%
$18.3M0.2%$298.56
0
2022-Q4
Decreased
1.3M
-3.0%
$28.7M0.3%$343.68
0
2022-Q3
Decreased
1.4M
-0.8%
$16.3M0.2%$189.12
0
2022-Q2
Decreased
1.4M
-3.0%
$18.3M0.2%$211.20
0
2022-Q1
Increased
1.4M
+1.3%
$29.9M0.2%$334.56
35
2021-Q4
Increased
1.4M
+2.2%
$28.6M0.2%$325.28
35
2021-Q3
Increased
1.4M
+15.7%
$41.9M0.3%$485.60
40
2021-Q2
Increased
1.2M
+15.6%
$34.7M0.3%$464.96
40
2021-Q1
Increased
1M
+1.8%
$44.4M0.4%$690.56
35
2020-Q4
Increased
1M
+1.2%
$46.8M0.5%$739.20
35
2020-Q3
Increased
1M
+42.8%
$43.4M0.5%$693.76
55
2020-Q2
Decreased
701,498
-10.9%
$37.3M0.5%$848.16
0
2020-Q1
Decreased
786,958
-26.7%
$17.4M0.3%$357.60
0
2019-Q4
First report
1.1M
-
$15.5M0.2%$233.76
0

Other major holders of BTAIQ: FMR LLC

Optional analytics helps us improve. How it’s used